+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance



Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance



AIDS 11(12): 1473-1478



Objective: To characterize the susceptibility to levofloxacin of clinical isolates of Mycobacterium tuberculosis (MTB) obtained from patients with HIV-related tuberculosis and to characterize the molecular genetics of levofloxacin resistance. Design and methods: isolates from culture-positive patients in a United States multicenter trial of HIV-related TB were tested for susceptibility to levofloxacin by minimum inhibitory concentration (MIC) determinations in Bactec 7H12 broth. Automated sequencing of the resistance determining region of gyrA was performed. Results: Of the 135 baseline MTB isolates tested, 134 (99%; 95% exact binomial confidence interval, 95.9-99.9%) were susceptible to levofloxacin with an MIC ltoreq 1.0 pg/ml. We identified a previously unrecognized mis-sense mutation occurring at codon 88 of gyrA in a levofloxacin mono-resistant MTB isolate obtained from a patient with AIDS who had received ofloxacin for 8 months prior to the diagnosis of tuberculosis. Conclusions: Clinical MTB isolates from HIV-infected patients were generally susceptible to levofloxacin. However, the identification of a clinical isolate with mono-resistance to levofloxacin highlights the need for circumspection in the use of fluoroquinolones in the setting of potential HIV-related tuberculosis and for monitoring of rates of resistance of MTB isolates to fluoroquinolones.

(PDF emailed within 0-6 h: $19.90)

Accession: 002973449

Download citation: RISBibTeXText

DOI: 10.1097/00002030-199712000-00011


Related references

Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team. Aids 11(12): 1473-1478, 1997

Susceptibility to Levofloxacin of Mycobacterium tuberculosis isolates from Patients in a Multicenter Treatment Study of HIV-related Tuberculosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35(0): 86, 1995

Susceptibility to levofloxacin of Mycobacterium tuberculosis strains with different genotype, isolated from the patients with first estimated and chronic tuberculosis. Antibiotiki i Khimioterapiya 47(6): 31-33, 2002

Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. Journal of Infection 61(2): 150-154, 2010

The structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates. Biomed Research International 2014: 367268, 2015

Levofloxacin susceptibility of Mycobacterium tuberculosis. Antibiotiki i Khimioterapiya 50(12): 16-18, 2005

Levofloxacin susceptibility of Mycobacterium tuberculosis. Antibiotiki i Khimioterapiia 50(12): 16-18, 2009

Study of susceptibility to levofloxacin of Mycobacterium tuberculosis strains. Antibiotiki i Khimioterapiya 47(6): 28-30, 2002

Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis. Antibiotiki i Khimioterapiia 47(6): 31-33, 2002

In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates. Tuberkuloz Ve Toraks 66(1): 32-36, 2018

Survey on arthritic pain experienced during the use of levofloxacin--a follow-up survey on the arthritic patients having participated in the "Survey on the use of levofloxacin used to treat tuberculosis" by the Therapeutic Committee, the Japanese Society for Tuberculosis. Kekkaku 89(8): 727-729, 2014

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model. International Journal of Antimicrobial Agents 42(6): 524-530, 2014

Validation of susceptibility testing of Mycobacterium tuberculosis to levofloxacin in middlebrook 7H10 agar, mycobacterial growth indicator tube , and BACTEC 12B media. Abstracts of the General Meeting of the American Society for Microbiology 101: 705, 2001

Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. Journal of Clinical Microbiology 45(2): 409-414, 2006

Decreased susceptibility to isoniazid associated to rifampin monoresistance in Mycobacterium tuberculosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 156, 2002